Find out more ways to treat psoriasis in the future

Published Date: 02 Mar 2023

According to MBA MD Andrew Blauvelt, the development of oral biologics and early treatment to replace the disease is a possibility.

Read Full News

Latest News

US Regulators Urge More Research on Testosterone Therapy for Women as Experts Debate Benefits, Risks

US health regulators on Thursday called for more data on testosterone therapies for women, with FDA officials urging manufacturers to conduct studies that could support...

FDA Grants Priority Review for Diabetic Foot Ulcer Therapy

The FDA has granted priority review for a novel wound-healing therapy for Wagner Grade 1 diabetic foot ulcers.

Pennsylvania Measles Cases Top 700 After Four Outbreak-related Deaths Reported

The Pennsylvania Department of Health on Wednesday reported 731 measles cases, up 38 from Monday's ⁠update, as the outbreak continued to spread in the state at the center of...

Fear of Relapse Burdens Patients With Vitiligo

Nearly half of patients with vitiligo who achieve repigmentation fear losing treatment gains, with relapse-related anxiety affecting psychological well-being even when skin improvement is maintained.

Adding IVIG to Prednisone Boosts Outcomes in IIMs

IVIG plus high-dose prednisone leads to improved disease activity and a faster response in newly diagnosed idiopathic inflammatory myopathies, but clotting remains a concern.

Smoke Exposure Tied to HS Risk in Children and Teens

Both passive and active exposure were associated with increased odds of diagnosis in pediatric and adolescent patients with hidradenitis suppurativa, a study reports.

Todays Updates

Annual Cancer Report Highlights Advances, Funding Threats

A yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.

Does Telenursing Improve QOL in Breast Cancer?

A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.

Long-Term Results Favor Acalabrutinib Combo in MCL

The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.

Todays Updates

Annual Cancer Report Highlights Advances, Funding Threats

A yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.

Does Telenursing Improve QOL in Breast Cancer?

A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.

Long-Term Results Favor Acalabrutinib Combo in MCL

The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.

Latest News

US health regulators on Thursday called for more data on testosterone therapies for women, with FDA officials urging manufacturers to conduct studies that could support...

The FDA has granted priority review for a novel wound-healing therapy for Wagner Grade 1 diabetic foot ulcers.

The Pennsylvania Department of Health on Wednesday reported 731 measles cases, up 38 from Monday's ⁠update, as the outbreak continued to spread in the state at the center of...

Nearly half of patients with vitiligo who achieve repigmentation fear losing treatment gains, with relapse-related anxiety affecting psychological well-being even when skin improvement is maintained.

IVIG plus high-dose prednisone leads to improved disease activity and a faster response in newly diagnosed idiopathic inflammatory myopathies, but clotting remains a concern.

Both passive and active exposure were associated with increased odds of diagnosis in pediatric and adolescent patients with hidradenitis suppurativa, a study reports.

News All Time

Criteria for Prescribing Testosterone: Who Qualifies?

A Brazilian multidisciplinary consensus sets thresholds for the diagnosis and treatment while emphasizing symptom assessment, repeated testing, and attention to the underlying causes.

Prostate Cancer Spending Nearly Quadrupled Over 10 Years

Medicare spending on prostate cancer care rose sharply from 2012 to 2021, driven largely by increased spending on systemic therapies.

Do IL-17 Inhibitors Increase IBD Risk in HS?

A meta-analysis finds no significant increase in the risk for inflammatory bowel disease among patients with hidradenitis suppurativa treated with IL-17 inhibitors.

Adjuvant Anti-PD-1 Boosts OS in Matched Melanoma Cases

Adjuvant anti-PD-1 therapy is tied to higher 5-year overall survival in patients with stage III melanoma in a matched analysis, but the population-level benefit remains unproven, a Danish study finds.

Kennedy Acknowledges One Measles Death in Pennsylvania

U.S. Health Secretary Robert F. Kennedy Jr acknowledged on Friday that measles caused the recent death of an infant in Pennsylvania, citing information from a county...

Do Pilots, Flight Crew Have Higher Cancer Mortality Risk?

Aircrew may be more likely to die from cancers potentially linked to radiation, but can that be attributed to cosmic radiation — and what, if anything, should physicians do differently?

Sunscreen, Collagen: Do Viral Social Media Claims Hold Up?

Viral discussions about sun protection, vitamin D, and oral collagen often outpace the evidence, leaving clinicians to weigh the benefits, limitations, and patient concerns.

AI-Tomography Detects Subclinical Basal Cell Skin Cancers

AI-assisted coherence tomography shows feasibility as a method of detecting basal cell carcinomas when they are still undetectable, but clinical relevance is still being evaluated.

Social Media Tied to Heavier Chemical Product Use in Teens

Teens who follow beauty influencers and watch skincare tutorials use far more personal care products, raising concerns over chemical exposure.

Young Adult Cancer Survival Rates Accelerate

Researchers have analyzed annual survival data between AYA patients aged 15-39 years and patients in younger and older age groups between 1975 and 2017.

GLP1R Expression Tied to Male Pattern Hair Loss

A genetic analysis suggests that increased GLP1R expression is linked to higher risk for male pattern hair loss.

Better Survival Seen With Spartalizumab Addition in Melanoma

More than 500 adults with BRAF V600-mutant cutaneous melanoma were randomly assigned to receive either intravenous spartalizumab plus oral dabrafenib and trametinib or oral dabrafenib and trametinib.

Advances in MCC: Q&A With Paul Nghiem, MD, PhD

Paul Nghiem, MD, PhD, a global expert in Merkel cell carcinoma, spoke with Medscape Dermatology about recent findings and trends in MCC care and research, as well as a look into the future.

Exclusive-Kennedy Asked to Remove Pennsylvania Measles Death From CDC Tally, Sources Say

U.S. Health Secretary Robert F. Kennedy Jr. asked his new CDC director to remove a reference to two Pennsylvania deaths from the agency’s online measles tally after he...

HS Severely Impairs Quality of Life, Even in Mild Disease

Quality of life is severely impaired in patients with hidradenitis suppurativa, including those traditionally classified as having mild disease.

Sofpironium Gel Safety Confirmed in Real-World Use

Real-world surveillance shows adverse events consistent with the known safety profile of sofpironium gel for excessive underarm sweating.

Recommended News For You

Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survival

New study highlights success of financial toxicity tumor board in reducing cancer treatment costs

AZD0486 Shows Good Efficacy in Relapsed/Refractory Follicular Lymphoma

Dual imaging capsule captures 3D tissue and blood vessel changes for early esophageal cancer diagnosis

Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

Examines Office-Based Transperineal Prostate Biopsies Methodology.

Recommended Articles For You

Critical Care Updates on Hematopoietic Dysfunction During Prolonged Critical Illness 

Beyond the Standard: Personalized Cancer Vaccines and the Dawn of a New Era in Pediatric Oncology 

Patient-Derived Response Maps for Therapy Selection: A Scientific Review 

Progressive Updates in Oncology for Healthcare Excellence 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy

2.

Compared to previous estimates, a greater number of patients participate in cancer treatment trials.

3.

Remote CBT for Insomnia Improves Symptoms During Chemo

4.

"We Caught It Early": Advantage or Disadvantage?

5.

Specific suicidal patterns mark the highest risk.

1.

The Latest Advances in Glioblastoma Treatment and Prevention 

2.

Geriatric Medicine Through Age-Associated Changes in Hematopoietic Reserve

3.

Angina Haemorrhagica Bullosa: What You Need to Know

4.

Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer

5.

Everything You Need to Know About HTLV: A Comprehensive Guide 

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Efficient Management of First line ALK-rearranged NSCLC - Part V

2.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

3.

The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I

5.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot